Beleave Inc. (CSE:BE)(CSE:BE.CN)(CSNX:BE)(OTCQX:BLEVF) is pleased to support initiatives like the “Don’t Drive High” campaign that make the public aware of the potential repercussions to driving under the influence. As we get closer to the legalization of recreational cannabis in Canada in July 2018, Ontario is planning on introducing tougher penalties for drivers caught under the influence.
“It is important to us that the implementation of recreational cannabis in Canada occurs as smoothly as possible. With all eyes on the industry we want to put our best foot forward,” stated Beleave Chief Science Officer Roger Ferreira, “Our message is simply that cannabis should be used responsibly. Impaired driving, which includes driving under the influence of cannabis, is illegal. However, there is a segment of the population that may be unaware of this or feel they are more attentive drivers after consuming cannabis. Our intention is to inform all drivers of the facts in an effective and memorable way.”
The Company’s goal in supporting the campaign is not to sell the advertised “Consequence Strains”, rather the goal, in partnership with R.I.D.E. CHECKS, is to start an important conversation, raise awareness and protect cannabis users from the dangers associated with driving impaired.
About Beleave
Beleave Inc. is a biotech company and Beleave’s wholly-owned subsidiary Beleave Kannabis Corp. (formerly First Access Medical Inc.) is a licensed producer pursuant to the ACMPR. Beleave’s purpose-built facility is located in Hamilton, Ontario.
In the interest of full disclosure, we call the reader’s attention to the fact that Equities.com, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by Equities.com to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle. Equities has been compensated with cash, common shares and/or warrants for market awareness services provided.
